Finally, we proposed and validated that the differentially expressed gene LOXL1 may influence the disease process by affecting the PI3K/AKT signaling pathway mediating inflammation in rheumatoid arthritis synovial cells. The gene discussed is LOXL1; the disease is rheumatoid arthritis.